Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
09/2005
09/01/2005US20050191630 Bioarray chip reaction apparatus and its manufacture
09/01/2005US20050191627 Enzymes
09/01/2005US20050191625 Polynucleotides for use as tags and tag complements, manufacture and use thereof
09/01/2005US20050191621 CD4-independent HIV envelope proteins as vaccines and therapeutics
09/01/2005US20050191618 chemically synthesized double stranded siNA against HIV-1 or HIV-2 RNA; treatment of HIV infection or AIDS
09/01/2005US20050191314 vaccine comprosing a mixture of A beta oligomers capable of generating an immune response; prophylaxis and treatment of Alzheimer's disease
09/01/2005US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
09/01/2005US20050191294 Peptide that selectively binds IL-11 receptor-alpha (IL11R alpha ); prostate and/or bone cancer, or adipose tissue; apoptosis induction; diagnosis, prognosis; staging metastatic cancer
09/01/2005US20050191292 of reversing cognitive decline by administering a humanized antibody that binds to A beta; particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease or Down's syndrome.
09/01/2005CA2558682A1 Targeted delivery of rna interference molecules for the treatment of ige-mediated disorders
09/01/2005CA2557595A1 Vectors having both isoforms of beta-hexosaminidase and uses of the same
09/01/2005CA2556913A1 Solid-fluid composition and uses thereof
09/01/2005CA2556594A1 3'-end nucleoside unit comprising phosphoramidite
09/01/2005CA2556593A1 Silyl linker for solid-phase synthesis of nucleic acid
09/01/2005CA2556435A1 Anti-microrna oligonucleotide molecules
09/01/2005CA2556418A1 Methods and materials using signaling probes
09/01/2005CA2556178A1 Methods and compositions for inferring eye color and hair color
09/01/2005CA2556027A1 Monoclonal antibodies that specifically block biological activity of a tumor antigen
09/01/2005CA2555737A1 Schizochytrium fatty acid synthase (fas) and products and methods related thereto
09/01/2005CA2541189A1 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in prokaryotes
08/2005
08/31/2005EP1568769A1 ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR
08/31/2005EP1568766A1 Device for pretreating specimen
08/31/2005EP1568705A1 Method and apparatus for concentration and purification of nucleic acid
08/31/2005EP1568704A1 Novel 2' ,5' -oligoadenylic acid analogues
08/31/2005EP1567675A2 Methods for using primers that encode one strand of a double-stranded promoter
08/31/2005EP1567672A2 Expression profiling based on histocultures
08/31/2005EP1567662A2 Caged sensors, regulators and compounds and uses thereof
08/31/2005EP1567540A2 Cftr allele detection assays
08/31/2005EP1567196A2 Modulation of notch3 expression
08/31/2005EP1567045A2 Methods for diagnosing the presence or stage of cancer
08/31/2005EP1567009A2 Antisense modulation of notch (drosophila) homolog 4 expression
08/31/2005EP1485502A4 Internal positive control for probe-based nucleic acid molecule assays and methods of making and using therof
08/31/2005EP1442137A4 Universal nucleotides for nucleic acid analysis
08/31/2005EP1263773A4 Oligonucleotide analogues, methods of synthesis and methods of use
08/31/2005EP1259264A4 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
08/31/2005EP0892808A4 Detection probes, kits and assays
08/31/2005EP0764214B1 Bioarray chip reaction apparatus and its manufacture
08/31/2005CN1662815A Functionalized nanoparticles and methods of use
08/31/2005CN1662663A DNA enzyme to inhibit plasminogen activator inhibitor-1
08/31/2005CN1662657A Low-cost production of peptides
08/31/2005CN1660900A CUDR as biomarker for cancer progression and therapeutic response
08/31/2005CN1660881A New type molecules of immunization stimulus and preparation method
08/31/2005CN1660880A Method for rapid separating rudimental DNA from isoflavone of soybean
08/31/2005CN1660879A Method for separating residual DNA from soy sauce, soybean milk and tomato ketchup
08/31/2005CN1660878A New method for rapid purifying DNA plasmid in large quantities
08/31/2005CN1660877A Nucleotide specific to O-antigen of 0177 type bacillus coli
08/31/2005CN1660876A Nucleotide specific to 0174 type O antigen of bacillus coli
08/31/2005CN1660875A Nucleotide specific to O-antigen of 025 type b acillus coli
08/31/2005CN1216995C DNA Sequence Coding for protein of A. thaliana having delta-5,7 terol, delta-7 reductase activity, delta T-red protein, production process strains of transformed yeasts uses
08/31/2005CN1216912C Human interleukin-17 receptor-like protein, its coding gene and use thereof
08/31/2005CN1216910C Novel liver regeneration related protein, its code sequence and application
08/31/2005CN1216901C Method for cleaving chimeric protein using processing enzyme
08/31/2005CN1216894C Nucleic acid amplification using hairping dtructure to produce signal ad detecting method
08/31/2005CN1216870C Serine-histamine acidamine and its preparation method and application
08/31/2005CN1216640C Live vaccine for human immunodeficiency virus
08/30/2005US6936705 nucleic acid sequence that is an insert of a clone selected from the group consisting of: yeast artificial chromosome, isolable from a transformant identified by international deposit number FERM BP-4271; BP-4273; BP-4274
08/30/2005US6936702 Charge-switch nucleotides
08/30/2005US6936698 Genetically engineered immunoglobulin; for use in treatment of hematopoietic defects
08/30/2005US6936695 Manufacture and expression of large structural genes
08/30/2005US6936694 [Met--1, des-Cys1, des-Tyr2, des-Cys3]IFN- gamma polypeptide produced by a DNA sequence coding in a transformant organism, and such polypeptide having the characteristics of human immune interferon
08/30/2005US6936693 Specific polypeptides, useful as nematocides
08/30/2005US6936688 Nucleotide sequences coding polypeptide for use in the treatment of leukemia, tumors, infections, autoimmune disease, and fibrotic disorders; wound healing agent
08/30/2005US6936593 Method of down-regulating gene expression
08/30/2005US6936472 Method for synthesizing a specific, surface-bound polymer uniformly over an element of a molecular array
08/30/2005US6936461 Method for immobilizing multistranded nucleic acid molecules by modifying more than one strand thereof, and binding each strand to a solid support
08/30/2005US6936422 Staphylococcus culture; genetic engineering
08/30/2005US6936418 Methods and compositions for effecting homologous recombination
08/25/2005WO2005078137A1 Methods and apparati using single polymer analysis
08/25/2005WO2005078136A1 Method of prognosis of metastasis by detection of fra12e fragile site within the smrt gene/locus at chromosome 12q24
08/25/2005WO2005078096A2 Dual functional oligonucleotides for use in repressing mutant gene expression
08/25/2005WO2005078088A1 Mechanism of separating and purifying dna and so on
08/25/2005WO2005078079A1 Phytate polynucleotides and methods of use
08/25/2005WO2005077967A1 Radiolabeled compounds and compositions, their precursors and methods for their production
08/25/2005WO2005077966A1 Substituted pixyl protecting groups for oligonucleotide synthesis
08/25/2005WO2005077126A2 Use of ppargamma specific inhibitors as anti-cancer therapeutics
08/25/2005WO2005077091A2 Nicotinamide riboside kinase compositions and methods for using the same
08/25/2005WO2005077084A2 Krüppel-like transcriptional factor klf4/gklf and uses thereof
08/25/2005WO2005076925A2 Dutp based compositions for reducing primer-aggregate formation during nucleic acid amplification
08/25/2005WO2005076908A2 Anti-freeze protein enhanced nucleic acid amplification
08/25/2005WO2005063816A3 Monovalent antibody fragments useful as therapeutics
08/25/2005WO2005047320A3 Equine p-selection glycoprotein ligand-1 and uses thereof
08/25/2005WO2005033134A3 Secreted protein therapeutics and uses thereof
08/25/2005WO2005030982A3 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs
08/25/2005WO2005030925A9 Microfluidic rotary flow reactor matrix
08/25/2005WO2005028615A3 Methods and compositions for detecting promoter activity and expressing fusion proteins
08/25/2005WO2005021585B1 Axmi-003, a delta-endotoxin gene and methods for its use
08/25/2005WO2005007829A3 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize
08/25/2005WO2004113500A3 B7s1: an immune modulator
08/25/2005WO2004093820A3 Methods and compositions for solid tumor treatment
08/25/2005WO2004059276A3 Rna bioassay
08/25/2005US20050188438 Compositions and methods using rna interference for control of nematodes
08/25/2005US20050187383 Oligonucleotide conjugates; peptide nucleic acids; sequencing; for treating cancer
08/25/2005US20050187382 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/25/2005US20050187379 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/25/2005US20050187178 Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
08/25/2005US20050187175 Methods and compositions for CPG15-2
08/25/2005US20050187174 RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)
08/25/2005US20050187162 Novel peptide with osteogenic activity
08/25/2005US20050186683 Combinatorial strategies for polymer synthesis
08/25/2005US20050186668 Hormonally up-regulated, neu-tumor-associated kinase
1 ... 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 ... 899